Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

publishing date : 2022 - 10 - 26    tags : Molecular    save search

4D Molecular Therapeutics Interim Clinical Data from the On-going Phase 1/2 Clinical Trial of 4D-710 for Cystic Fibrosis Lung Disease to be Presented at NACFC 2022
Published: 2022-10-26 (Crawled : 21:00) - globenewswire.com
FDMT M | $24.25 -2.26% -2.29% 290K twitter stocktwits trandingview |
Health Technology
| | O: 1.17% H: 34.79% C: 14.63%

fibrosis lung disease trial therapeutics molecular cystic fibrosis
Delisting of Securities of Evofem Biosciences, Inc.; Creatd Inc.; Molecular Data Inc.; ECMOHO Limited; and ALFI, Inc. from The Nasdaq Stock Market
Published: 2022-10-26 (Crawled : 21:00) - globenewswire.com
NDAQ | $61.5 0.67% 0.68% 2.3M twitter stocktwits trandingview |
Finance
| | O: 0.6% H: 1.76% C: 0.43%
CRTD | $1.82 0.55% 122.27% 3.4K twitter stocktwits trandingview |
Technology Services
| | O: -5.79% H: 4.34% C: -6.55%

molecular market
Black Diamond Therapeutics Presents Preclinical Data on BDTX-1535 and BDTX-4933 at the 34th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
Published: 2022-10-26 (Crawled : 12:20) - globenewswire.com
BDTX | $5.06 1.0% 0.79% 360K twitter stocktwits trandingview |
Health Technology
| | O: 0.6% H: 11.98% C: 4.19%

bdtx-1535 preclinical symposium therapeutics molecular cancer
Hamilton and Bionano Genomics Announce Commercial Availability of World’s First Ultra High Molecular Weight DNA Extraction Automation Solution for OGM
Published: 2022-10-26 (Crawled : 12:20) - globenewswire.com
BNGO | $0.7611 -4.19% -3.78% 790K twitter stocktwits trandingview |
Health Technology
| | O: 1.28% H: 16.03% C: 7.17%

dna commercial genomics molecular
Merus Presents First in Human Data on MCLA-129 at the 34th EORTC/NCI/AACR (ENA) Symposium on Molecular Targets and Cancer Therapeutics
Published: 2022-10-26 (Crawled : 09:00) - globenewswire.com
MRUS | $41.97 2.82% 2.72% 740K twitter stocktwits trandingview |
Health Technology
| | O: -1.06% H: 3.59% C: -8.84%

mcla-129 symposium therapeutics molecular cancer
Gainers vs Losers
61% 39%

Top 10 Gainers
CSSE 4 | $0.4253 179.25% 64.77% 210M twitter stocktwits trandingview |
Consumer Services

BOF | $2.08 77.78% 41.21% 110M twitter stocktwits trandingview |

ILAG | $0.54 12.27% 40.62% 3.7M twitter stocktwits trandingview |

LICN | $0.999 78.39% 40.49% 15M twitter stocktwits trandingview |

AMST | $3.4 70.0% 39.58% 70M twitter stocktwits trandingview |
Technology Services

MTC | $3.6 60.71% 38.04% 9.1M twitter stocktwits trandingview |
Technology Services

WIMI | $1.15 58.53% 36.92% 19M twitter stocktwits trandingview |
Technology Services

AIH | $0.458 14.5% 30.92% 91K twitter stocktwits trandingview |
Health Services

WHLM | $6.25 35.87% 28.46% 700K twitter stocktwits trandingview |
Commercial Services

MULN | News | $3.77 38.1% 27.78% 13M twitter stocktwits trandingview |
Information


Your saved searches
Save your searches and get alerts when important news are released.